Vice President, Communications and Research
Anne McNickle, Vice President, Communications and Research, is a health policy expert and strategist with over 28 years of experience spanning the biopharma industry, consulting, and journalism.
Ms. McNickle specializes in regulatory strategy, policy analysis, and communications. She leads strategic research projects and analyzes policy issues and trends for biopharma and medtech clients.
At Amgen, she provided strategic advice on the impact of changes to federal and state coverage and reimbursement policy to the company’s Business Units and executive team. She also served in a range of strategic communications roles, working with national media and trade press and showcasing the company’s scientific innovation.
Earlier in her career, she held policy analyst roles at several DC-area consulting firms. She began her career in pharmaceutical/health care journalism, serving in a range of positions at FDC Reports in Washington, DC. Over the course of her tenure there, she led a staff of reporters as Managing Editor of Health News Daily; served as Capitol Hill Editor for The Pink Sheet; and covered regulatory, political, and business news affecting the biopharma industry.
Ms. McNickle received her BA from the College of William and Mary.